Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Structural Genomics Consortium (SGC) and its clinical, industry and disease-foundation partners are launching open-source preclinical translational medicine studies.

Original publication

DOI

10.1038/nrd4565

Type

Journal article

Journal

Nature reviews. Drug discovery

Publication Date

03/2015

Volume

14

Pages

149 - 150

Addresses

Structural Genomics Consortium, University of Toronto, 101 College Street, Toronto, Ontario M5G 1L7, Canada.

Keywords

SGC Open Source Target-Discovery Partnership, Cell Line, Humans, Drug Evaluation, Preclinical, Patients, Public-Private Sector Partnerships, Primary Cell Culture, Translational Medical Research